BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26364927)

  • 1. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
    Hofman J; Kučera R; Neumanova Z; Klimes J; Ceckova M; Staud F
    Xenobiotica; 2016; 46(5):416-23. PubMed ID: 26364927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olomoucine II, but not purvalanol A, is transported by breast cancer resistance protein (ABCG2) and P-glycoprotein (ABCB1).
    Hofman J; Kučera R; Cihalova D; Klimes J; Ceckova M; Staud F
    PLoS One; 2013; 8(10):e75520. PubMed ID: 24116053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
    Neumanova Z; Cerveny L; Ceckova M; Staud F
    AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone.
    Hofman J; Ahmadimoghaddam D; Hahnova L; Pavek P; Ceckova M; Staud F
    Pharmacol Res; 2012 Mar; 65(3):312-9. PubMed ID: 22173067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics.
    Tupova L; Ceckova M; Ambrus C; Sorf A; Ptackova Z; Gaborik Z; Staud F
    Drug Metab Dispos; 2019 Sep; 47(9):954-960. PubMed ID: 31266750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxygen on multidrug resistance in the first trimester human placenta.
    Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
    Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats.
    Cerveny L; Ptackova Z; Durisova M; Staud F
    Reprod Toxicol; 2018 Aug; 79():57-65. PubMed ID: 29859254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate.
    Reznicek J; Ceckova M; Tupova L; Staud F
    Placenta; 2016 Nov; 47():124-129. PubMed ID: 27780535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.
    Ceckova M; Reznicek J; Ptackova Z; Cerveny L; Müller F; Kacerovsky M; Fromm MF; Glazier JD; Staud F
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5563-72. PubMed ID: 27401571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.
    Cihalova D; Ceckova M; Kucera R; Klimes J; Staud F
    Biochem Pharmacol; 2015 Dec; 98(3):465-72. PubMed ID: 26300056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine.
    Neumanova Z; Cerveny L; Ceckova M; Staud F
    Biopharm Drug Dispos; 2016 Jan; 37(1):28-38. PubMed ID: 26390406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxygen on multidrug resistance in term human placenta.
    Javam M; Audette MC; Iqbal M; Bloise E; Gibb W; Matthews SG
    Placenta; 2014 May; 35(5):324-30. PubMed ID: 24685282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line.
    Staud F; Vackova Z; Pospechova K; Pavek P; Ceckova M; Libra A; Cygalova L; Nachtigal P; Fendrich Z
    J Pharmacol Exp Ther; 2006 Oct; 319(1):53-62. PubMed ID: 16809480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility.
    Cygalova LH; Hofman J; Ceckova M; Staud F
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1118-25. PubMed ID: 19779128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir.
    Neumanova Z; Cerveny L; Greenwood SL; Ceckova M; Staud F
    Reprod Toxicol; 2015 Nov; 57():176-82. PubMed ID: 26169552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods.
    Cerveny L; Karbanova S; Karahoda R; Horackova H; Jiraskova L; Ali MNH; Staud F
    Toxicol Appl Pharmacol; 2023 Mar; 463():116427. PubMed ID: 36801311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.
    Joshi AA; Vaidya SS; St-Pierre MV; Mikheev AM; Desino KE; Nyandege AN; Audus KL; Unadkat JD; Gerk PM
    Pharm Res; 2016 Dec; 33(12):2847-2878. PubMed ID: 27644937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.